Common Sense Oncology: including everyone - Authors' reply
- PMID: 37797642
- DOI: 10.1016/S1470-2045(23)00464-3
Common Sense Oncology: including everyone - Authors' reply
Conflict of interest statement
AG reports consulting fees from Seattle Genetics and speaking honoraria from Curio. BW reports research funding from Bristol Myers Squibb, Ontario Institute of Cancer Research, Queen's University, National Breast Cancer Foundation of Australia, and the Kidney Cancer Research Network of Canada; and honoraria from AstraZeneca. BG reports consulting fees from Vivio Health. All other authors declare no competing interests.
Comment on
-
Common Sense Oncology: including everyone.Lancet Oncol. 2023 Oct;24(10):e402. doi: 10.1016/S1470-2045(23)00413-8. Lancet Oncol. 2023. PMID: 37797640 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
